← Eichor
Study identifier: NCT07425015 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Ambulatory Long Length URodynamics Evaluation

Condition: Urology · Urinary Bladder, Overactive · Benign Prostatic Hyperplasia  ·  Sponsor: Bright Uro

PhaseNA
Planned participants101
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

A prospective, open-label, single arm interventional trial evaluating the safety and performance of the in-clinic and extended monitoring of the lower urinary tract using the Glean Urodynamics System.

This description comes directly from the study's public registry record.

Talk to the study team

Brittany U Carter, DHSc, MPH  ·  949-202-5689  ·  brittany@brighturo.com

Suranjan Roychowdhury, PhD  ·  949-202-5685  ·  suranjan@brighturo.com

Always discuss trial participation with your own doctor first.

Locations (7)

Chesapeake Urology AssociatesHanover, Maryland, United StatesRecruiting
Chesapeake Urology AssociatesOwings Mills, Maryland, United StatesRecruiting
Urology of St. LouisSt Louis, Missouri, United StatesRecruiting
MetroHealthCleveland, Ohio, United StatesRecruiting
Southern Urogynecology Wellness & AestheticsWest Columbia, South Carolina, United StatesRecruiting
Sanford HealthSioux Falls, South Dakota, United StatesRecruiting
Urology Partner of North TexasArlington, Texas, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07425015